Production (Stage)
InnoCan Pharma Corporation
INNPF
$0.114
-$0.007-5.79%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -582.00K | -114.00K | -290.00K | 337.00K | -1.77M |
| Total Depreciation and Amortization | 10.00K | 6.00K | 9.00K | 10.00K | 10.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 917.00K | -444.00K | 436.00K | 13.00K | 1.42M |
| Change in Net Operating Assets | 23.00K | 48.00K | -1.16M | 315.00K | -408.00K |
| Cash from Operations | 368.00K | -504.00K | -1.00M | 675.00K | -747.00K |
| Capital Expenditure | -5.00K | -4.00K | -6.00K | -3.00K | -2.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.00K | 69.00K | -- | -- | -- |
| Cash from Investing | -4.00K | 65.00K | -6.00K | -3.00K | -2.00K |
| Total Debt Issued | 640.00K | -- | -- | -- | -- |
| Total Debt Repaid | -4.00K | -6.00K | -6.00K | -5.00K | -5.00K |
| Issuance of Common Stock | -- | -- | 395.00K | 0.00 | 619.00K |
| Repurchase of Common Stock | -- | -123.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 360.00K | 529.00K | 470.00K | 0.00 | 836.00K |
| Cash from Financing | 996.00K | 400.00K | 859.00K | -5.00K | 1.45M |
| Foreign Exchange rate Adjustments | -3.00K | -10.00K | 18.00K | -73.00K | 9.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.36M | -49.00K | -132.00K | 594.00K | 710.00K |